JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 29, 2007; DOI: 10.1124/jpet.106.118018


0022-3565/07/3221-70-79$20.00
JPET 322:70-79, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.118018v1
322/1/70    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coates, S. S. A.
Right arrow Articles by Gary, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coates, S. S. A.
Right arrow Articles by Gary, R. K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*BERYLLIUM, ELEMENTAL

CELLULAR AND MOLECULAR

Beryllium Induces Premature Senescence in Human Fibroblasts

Shannon S. A. Coates, Bruce E. Lehnert, Sunil Sharma, Susan M. Kindell, and Ronald K. Gary

Department of Chemistry, University of Nevada, Las Vegas, Las Vegas, Nevada (S.S.A.C., S.M.K., R.K.G.); Bioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico (B.E.L.); and Nevada Cancer Institute, Las Vegas, Nevada (S.S.)

After cells have completed a sufficient number of cell divisions, they exit the cell cycle and enter replicative senescence. Here, we report that beryllium causes proliferation arrest with premature expression of the principal markers of senescence. After young presenescent human fibroblasts were treated with 3 µM BeSO4 for 24 h, p21 cyclin-dependent kinase inhibitor mRNA increased by >200%. Longer periods of exposure caused mRNA and protein levels to increase for both p21 and p16(Ink4a), a senescence regulator that prevents pRb-mediated cell cycle progression. BeSO4 also caused dose-dependent induction of senescence-associated beta-galactosidase activity (SA-beta-gal). Untreated cells had 48 relative fluorescence units (RFU)/µg/h of SA-beta-gal, whereas 3 µM BeSO4 caused activity to increase to 84 RFU/µg/h. In chromatin immunoprecipitation experiments, BeSO4 caused p53 protein to associate with its DNA binding site in the promoter region of the p21 gene, indicating that p53 transcriptional activity is responsible for the large increase in p21 mRNA elicited by beryllium. Forced expression of human telomerase reverse transcriptase (hTERT) rendered HFL-1 cells incapable of normal replicative senescence. However, there was no difference in the responsiveness of normal HFL-1 fibroblasts (IC50 = 1.9 µM) and hTERT-immortalized cells (IC50 = 1.7 µM) to BeSO4 in a 9-day proliferation assay. The effects of beryllium resemble those of histone deacetylase-inhibiting drugs, which also cause large increases in p21. However, beryllium produced no changes in histone acetylation, suggesting that Be2+ acts as a novel and potent pharmacological inducer of premature senescence.


Received November 30, 2006; accepted March 28, 2007.

Address correspondence to: Dr. Ronald K. Gary, Department of Chemistry, University of Nevada, Las Vegas, 4505 Maryland Parkway, Las Vegas, NV 89154-4003. E-mail: ronald.gary{at}unlv.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.